The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV infusion therapy given once a month to people in the early stages of Alzheimer's, according to the ...
Jul 15, 2024
0
0
Despite treatment-related fertility challenges, female patients can become pregnant and give birth to healthy children after undergoing allogeneic hematopoietic cell transplantation (alloHCT), according to a study published ...
Jul 15, 2024
0
0
Scientists at Nottingham Trent University, the University of Nottingham, Stanford University and the University of California and Cedars-Sinai Medical Center, Los Angeles, have found that the molecule "HNF4A" suppresses pancreatic ...
Jul 15, 2024
0
47
Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS ...
Jul 14, 2024
0
16
Five cases of neonatal enterovirus infection have been reported in San Diego, highlighting the risks and need for timely identification and treatment, according to data published in the July 11 issue of the U.S. Centers for ...
Jul 14, 2024
0
2
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer's disease.
Jul 12, 2024
0
38
Physical therapy can be a life changer, helping people address chronic pain, recovery from surgery or injury, or getting back to a beloved sport. But that's only if physical therapy is done—and done right.
Jul 12, 2024
0
0
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).
Jul 12, 2024
0
1
Since the early 20th century, researchers believed that movements on the right and left sides of the body were controlled by the opposite hemisphere of the brain and that handedness resulted from the dominant side doing a ...
Jul 12, 2024
0
36
A model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast cancer patients who would previously have been advised to consider the treatment.
Jul 12, 2024
0
6
